Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.

ABSTRACT:

Background

Clinical trials have found that a monthly dapivirine vaginal ring was well-tolerated and reduced HIV-1 risk among women in sub-Saharan Africa. However, in order for the ring or other novel prevention methods to have optimal impact, it is necessary to understand and address women's challenges to uptake and adherence. This paper provides insight into a few key challenges noted by women using the ring and contraceptives simultaneously.

Methods

The qualitative portion of the MTN-020/ASPIRE study consisted of data collection using single in-depth interviews, serial in-depth interviews, and focus group discussions, conducted with 214 participants across 15 sites in Malawi, South Africa, Uganda and Zimbabwe. A coding team used qualitative analysis software to identify th

SUBMITTER: Leslie J 

PROVIDER: S-EPMC8067655 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature